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Abstract
Background: Food-producing animals, mainly poultry, have been associated with the maintenance and dissemination
of antibiotic-resistant bacteria, such as plasmid-mediated AmpC (pAmpC)-producing Enterobacteriaceae, to humans,
thus impacting food safety. Many studies have shown that Escherichia coli strains isolated from poultry and humans
infections share identical cephalosporin resistance, suggesting that transmission of resistance from poultry meat to
humans may occur. The aim of this study was to characterize pAmpC-producing E. coli strains isolated from chicken
carcasses and human infection in a restrict area and to determine their antimicrobial resistance profiles, and molecular
type by multilocus sequence typing (MLST) and pulsed-field gel electrophoresis (PFGE).
Results: A total of 14 pAmpC-producing E. coli strains were isolated, including eight strains from chicken carcasses and
six strains from human infections (from urine, tissue and secretion). The blaCMY-2 gene was identified in all pAmpC-
producing E. coli strains by polymerase chain reaction (PCR) and DNA sequencing. High percentages of strains resistant
to tetracycline, nalidixic acid and sulfamethoxazole-trimethoprim (78–92%) were detected, all of which were
considered multidrug-resistant. Among the non-beta-lactam resistance genes, the majority of the strains showed tetA,
tetB, sulI and sulII. No strain was considered an extended-spectrum beta-lactamases (ESBL) producer, and the blaTEM-1
gene was found in 2 strains isolated from human infection. Six strains from chicken carcasses and four strains from
humans infections were linked to an ISEcp1-like element. Through MLST, 11 sequence types were found. Three strains
isolated from human infection and one strain isolated from chicken carcasses belonged to the same sequence type
(ST354). However, considerable heterogeneity between the strains from chicken carcasses and humans was confirmed
by PFGE analysis.
Conclusion: This study showed the prevalence of E. coli strains producing blaCMY-2 linked to ISEcp1 that were present
in both chickens and humans in a restricted area. Our results also suggest the presence of a highly diverse strains that
harbor pAmpC, indicating no clonal dissemination. Therefore, continuous monitoring and comparative analyses of
resistant bacteria from humans and food-producing animals are needed.
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Background
Food-producing animals have been associated with the
maintenance and dissemination of antimicrobial-resistant
bacteria to humans, impacting food safety. Studies have
indicated that poultry meat is an important reservoir for
resistance problems rapidly emerging worldwide due to
bacterial selection caused by antimicrobial agents used as
growth promoters or for prophylactic and therapeutic
purposes [1–4].
In recent years, the frequency of resistance to third-
generation cephalosporins has increased both in
strains isolated from human infections and from the
colonization of food-producing animals, mainly mediated
by extended-spectrum beta-lactamases (ESBL) and the
AmpC-beta-lactamase. However, the epidemiology of
AmpC-producing bacteria may be underreported due to
the lack of a phenotypic test for the detection of this
mechanism of resistance. Failure to detect this beta-lacta-
mase has contributed to its uncontrolled spread and occa-
sional therapeutic failure [5–8].
Bacteria overexpressing AmpC beta-lactamases are
usually resistant to all beta-lactam antibiotics, except ce-
fepime, cefpirome, and carbapenems, which is an im-
portant clinical concerns because the bacteria often
express a multidrug-resistant phenotype, leaving limited
therapeutic options. The AmpC beta-lactamase can be
encoded by genes located on chromosomes or plasmids.
In Escherichia coli, the expression of the chromosome-
encoded AmpC beta-lactamase is very low, due to the
absence of the ampR regulator gene. On the other hand,
the genes that encode plasmid-mediated AmpC beta-lac-
tamases (pAmpC) in E. coli are often overexpressed and
have been found around the world in nosocomial and
non-nosocomial isolates. Plasmid-mediated ampC genes
originated from chromosomal ampC genes carried by
several gram-negative species and are classified into at
least five phylogenetic groups, namely, the Enterobacter
group (MIR, ACT), the Citrobacter freundii group
(CMY-2-like, LAT, CFE), the Morganella morganii group
(DHA), the Hafnia alvei group (ACC), and the Aeromo-
nas group (CMY-1like, FOX, MOX), with the most
prevalent and widely disseminated being CMY-2-like
enzymes. The presence of AmpC in plasmids has
contributed to the rapid spread of this mechanism of
resistance [5, 7, 9].
The prevalence of pAmpC-producing E. coli varies sig-
nificantly depending on the geographical region and
host, with a high prevalence in both humans and food-
producing animals mainly in North America [2–4]. In
Brazil, pAmpC betalactamases were first reported in
strains isolated from humans between 2007 and 2008
[10, 11]. Since then, AmpC-producing bacteria have
been reported in food-producing animals, such as poultry
carcasses [12–16]. However, there are few studies on
AmpC-mediated resistance in human clinical and veterin-
ary medicine in Brazil. As Brazil is one of the largest
chicken meat exporters in the world and our work has
pointed out a significant increase in the presence of beta-
lactamases in chicken meat from Brazil [12], an investiga-
tion of the spread of AmpC genes in food-producing ani-
mals is also important to elucidate the origin of resistant
strains. The aim of our study was characterize pAmpC-
producing E. coli strains from both chicken carcasses and
human clinical samples from a city in southern Brazil
(Paraná state) within close time periods to determine
whether chicken meat might act as a reservoir and
dissemination route for pAmpC-producing E. coli.
These strains were studied regarding their antimicro-
bial resistance profiles and molecular typing by multi-
locus sequence typing (MLST) and pulsed-field gel
electrophoresis (PFGE).
Methods
Bacterial isolates
In 2013, a study performed by our group [12] isolated
121 E. coli strains from commercial refrigerated chicken
carcasses intended only for local consumption that were
sold in a city in southern Brazil. From these strains, 8
were screened and confirmed as pAmpC-producing
strains by polymerase chain reaction (PCR) described by
Pérez-Pérez and Hanson (2002) [7]. These strains belong
to the collection of the Basic and Applied Bacteriology
Laboratory from State University of Londrina (UEL),
Londrina, PR, Brazil. Between 2013 and 2015, 6 E. coli
strains isolated from human infection (from urine, tissue
and secretion) were confirmed as pAmpC by the Vitek
system GNID card (bioMérieux, Marcy I’Etoile, France)
and PCR [7] (Table 1). Only one isolate was selected per
patient. These strains were provided by the University
Hospital of Londrina, Londrina, Paraná, Brazil.
Antimicrobial susceptibility testing
Antimicrobial susceptibility testing of E. coli isolates was
performed using the standard disk-diffusion method rec-
ommended by the Clinical and Laboratory Standards Insti-
tute [24, 25], with the following antimicrobials: ciprofloxacin
(5 μg), gentamicin (10 μg), norfloxacin (10 μg), enrofloxacin
(10 μg), cefotaxime (30 μg), cefoxitin (30 μg), ceftazidime
(30 μg), tetracycline (30 μg), nalidixic acid (30 μg), chloram-
phenicol (30 μg), nitrofurantoin (300 μg), trimethoprim-
sulfamethoxazole (1.25/23.75 μg) and amoxicillin-clavulanic
acid (20/10 μg) (Oxoid Ltd., Basingstoke, Hants, UK). For
the negative control, we used E. coli strain ATCC 25922. All
strains resistant to 3rd generation cephalosporins were
tested for phenotypic confirmation of ESBL production by
standard ceftazidime and cefotaxime disks combined with
clavulanic acid [25] and by the double-disk diffusion method
with disks containing cefepime, cefotaxime, ceftazidime and
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Table 1 Oligonucleotide used for amplification in the PCR
Target Gene Oligonucleotide sequence (5′ to 3′) References
blaESBL blaCTX-M-1 group F- AAA AAT CAC TGC GCC AGT TC [17]
R- AGC TTA TTC ATC GCC ACG TT
blaCTX-M2 group F- CGA CGC TAC CCC TGC TAT T
R- CCA GCG TCA GAT TTT TCA GG
blaCTX-M8 group F- TCG CGT TAA GCG GAT GAT GC
R- AAC CCA CGA TGT GGG TAG C
blaCTX-M9 group F- CAA AGA GAG TGC AAC GGA TG
R- ATT GGA AAG CGT TCA TCA CC
blaCTX-M25 group F- GCA CGA TGA CAT TCG GG
R- AAC CCA CGA TGT GGG TAG C
blaTEM F- CAT TTC CGT GTC GCC CTT ATT C [18]
R- CGT TCA TCC ATA GTT GCC TGA C
blaSHV F- CAC TCA AGG ATG TAT TGT G [19]
R- TTA GCG TTG CCA GTG CTC G
blapAmpC blaMOX-1, blaMOX-2, blaCMY-1, blaCMY-8 to blaCMY-11 F- GCT GCT CAA GGA GCA CAG GAT [7]
R- CAC ATT GAC ATA GGT GTG GTG C
blaLAT-1 to blaLAT-4, blaCMY-2 to blaCMY-7, blaBIL-1 F- TGG CCA GAA CTG ACA GGC AAA
R- TTT CTC CTG AAC GTG GCT GGC
blaDHA-1 and blaDHA-2 F- AAC TTT CAC AGG TGT GCT GGG T
R- CCG TAC GCA TAC TGG CTT TGC
blaACC F- AAC AGC CTC AGC AGC CGG TTA
R- TTC GCC GCA ATC ATC CCT AGC
blaMIR-1T, blaACT-1 F- TCG GTA AAG CCG ATG TTG CGG
R- CTT CCA CTG CGG CTG CCA GTT
blaFOX-1 to blaFOX-5b F- AAC ATG GGG TAT CAG GGA GAT G
R- CAA AGC GCG TAA CCG GAT TGG
blaCMY-2, blaCMY-4, blaCMY-6, blaCMY-7, blaCMY-12,
blaCMY-13, blaCMY-14, blaCMY-18, blaLAT-3
F- ATG ATG AAA AAA TCG TTA TGC TGC [20]
R- GCT TTT CAA GAA TGC GCC AGG
PMQR qnrA F- AGA GGA TTT CTC ACG CCA GG [21]
R- TGC CAG GCA CAG ATC TTG AC
qnrB F- GGM ATH GAA ATT CGC CAC TG
R- TTT GCY GYY CGC CAG TCG AA
qnrS F- GCA AGT TCA TTG AAC AGG GT
R- TCT AAA CCG TCG AGT TCG GCG
Tetracycline resistance tetA F- GCC TTT CCT TTG GGT TCT CT [22]
R- TGT CCG ACA AGT TGC ATG AT
tetB F- GCT TTC AGG GAT CAC AGG AG
R- GAC CAA GAC CCG CTA ATG AA
Sulfonamide resistance sulI F- ACG AGA TTG TGC GGT TCT TC [22]
R- GGT TTC CGA GAT GGT GAT TG
sulII F- CCG TCT CGC TCG ACA GTT AT
R- GTG TGT GCG GAT GAA GTC AG
Insertion sequence ISEcp1 - CMY F- AAA AAT GAT TGA AAG GTG GT [7, 23]
R- TTT CTC CTG AAC GTG GCT GGC
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aztreonam placed 25mm apart (center to center) to a disk
containing a beta-lactamase inhibitor (amoxicillin-clavulanic
acid) [26].
Screening of antimicrobial resistance genes and insertion
sequence
All E. coli strains were screened by PCR for blaCMY gene
as described by Dierikx and collaborators (2010) and
sequenced [20] (Table 1). For sequencing, amplicons
were purified with a column-based kit (Pure Link
Quick PCR Purification Kit, Invitrogen, Germany).
The purified product was sequenced based on Sanger
methodology using an ABI PRISM 3500xL Genetic
Analyzer (Applied Biosystems, Foster City, CA). The
sequencing was performed at the Multiuser Labora-
tory of Genotyping and Sequencing from State University
of Campinas (UNICAMP) and in the Soil Biotechnology
Laboratory from the Brazilian Agricultural Research
Corporation (Embrapa).
After sequencing, homology searches were done based
on the BLAST algorithm available at http://blast.ncbi.
nlm.nih.gov/Blast.cgi. The DNA sequences were com-
pared with reference sequences from the LAHEY home
page (http://www.lahey.org/Studies/).
The strains were also analyzed for the presence of
other major beta-lactamase genes (blaCTX-M, blaSHV, bla-
TEM), plasmid mediated quinolone resistance (PMQR)
determinants (qnrA, qnrB and qnrS), sulfonamide resist-
ance genes (sulI and sulII) and tetracycline resistance
genes (tetA and tetB) [7, 17–22]. To define the mechan-
ism of transmission of the pAmpC gene, we screened
blaampC for the insertion sequence ISEcp1 by ISEcp1-
blaCMY linkage PCR [23]. Strains positive for this PCR
were sequenced as previously described. Details regard-
ing oligonucleotide primers and references are illustrated
in Table 1. The PCR mixture was prepared using Pro-
mega PCR Master Mix (Promega, USA). PCR amplicons
were visualized on 2.0% agarose gels stained with GelRed
(Biotium). After gel electrophoresis, the images were
captured using an Image Capture System (LPixIma-
geHE). Strains positive for beta-lactamases (non AmpC-
type) were also sequenced as previously described.
Multilocus sequence typing
MLST was performed according to the Achtman scheme
(http://mlst.warwick.ac.uk/mlst/dbs/Ecoli), for sequen-
cing the PCR amplificon adk, fumC, gyrB, icd, mdh,
purA and recA. Sequencing was performed as previously
described in this manuscript.
Pulsed-field gel electrophoresis
Genomic relationships were analyzed by XbaI restriction
digestion followed by pulsed-field gel electrophoresis
(PFGE) using the CHEF DR III PFGE System (BioRad,
Hercules, CA, USA). Electrophoresis conditions con-
sisted of an initial time of 2.2 s, a final time of 54.2 s at a
gradient of 6 Vcm− 1 and an included angle of 120°. The
gels were electrophoresed for 18 h. The results were
evaluated with BioNumerics (version 7.6; Applied Maths,
Austin, TX, USA) using the cut-off value of 80% similar-
ity to distinguish PFGE types.
Results
A total of 14 strains (8 strains isolated from chicken car-
casses and 6 strains isolated from humans infections)
were confirmed as pAmpC-producing strains by PCR.
The strains from humans infections were isolated from
urine (N = 4), a fragment of sacral ulcer tissue (N = 1)
and secretion of an abdominal surgical wound (N = 1)
(Fig. 1). PCR and sequencing, using specific primers
(Table 1) identified the blaCMY-2 gene in all pAmpC-pro-
ducing E. coli strains.
All the strains were resistant to amoxicillin-clavu-
lanic acid, and 92.86% of the strains were resistant
to cefoxitin. According to the antimicrobial sus-
ceptibility profile for non-beta-lactam antimicrobials,
the strains presented a high frequency of resistance
for mainly tetracycline (92.86%), nalidixic acid
(92.86%) and sulfamethoxazole-trimethoprim (78.57%)
(Table 2). Among the non-beta-lactamase genes, the
strains showed tetA (7 from chickens and 2 from
humans), tetB (6 from chickens and 3 from humans),
sulI (8 from chickens) and sulII (7 from chickens and
1 from humans) (Table 2). PMQRs were not found.
All strains were considered multidrug-resistant (non-
susceptible to at least 1 agent in 3 or more antimicrobial
categories) [27].
ESBL production, by phenotypic testing, was not
observed for any strain. In addition, the blaTEM-1 gene
was found in 2 strains isolated from human.
To detect whether ISEcp1 is upstream of blaCMY-2,
PCR with a forward primer targeting the ISEcp1 element
and a reverse primer targeting the blaCMY genes was
performed, and the amplicons of positive strains were
sequenced. Ten strains (6 from chicken carcasses and 4
from human infection) were positive, and sequencing
confirmed that blaCMY-2 genes are linked to an upstream
ISEcp1-like element.
By MLST, 11 sequence types (STs) were found. Three
strains isolated from human infection (2 from urine and
1 from tissue) and one strain isolated from a chicken
carcass belonged to ST354 (Fig. 1).
The AmpC-beta-lactamase-producers were classified
within 13 PFGE types, showing high diversity among
strains. Only two strains of ST354 from human urine
and tissue (U79167 and T746 strains) showed 100%
similarity (Fig. 1).
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Discussion
The emergence of third-generation cephalosporin-resistant
Enterobacteriaceae, such as expressing ESBL and AmpC, in
food-producing animals and their products has impacted
the health of consumers, leading to the hypothesis that ani-
mals might become antimicrobial resistance sources and/or
even contribute to the spread of these bacteria. Recent
studies have shown that poultry and humans share similar
antimicrobial resistance genes, and E. coli strain types, sug-
gesting that transmission from poultry to humans may
occur [2–4]. The presence of similar pAmpC in
strains isolated from chicken meat and human clinical
samples, in the same city and similar time period led
us to compare the similarity of these strains by PFGE
and MLST methodologies and to determine their
antimicrobial resistance profiles to understand the
dissemination of this mechanism of resistance.
In 2013, our group identified 8 pAmpC-producing E.
coli isolates from chicken carcasses [12]. Near this time
period, 6 pAmpC-producing E. coli were also isolated
from patients with infection from a hospital in the same
city where our study was conducted with chicken
carcasses. All pAmpC of these strains, from chicken
carcasses and human infection, were identified as the
blaCMY-2 gene by sequencing. According to the litera-
ture, blaCMY-2 is the most common pAmpC gene identi-
fied from widespread human and veterinary medical
cases [2–4]. Initially, in Brazil, pAmpC-producing bacteria
Fig. 1 Relationship among pAmpC-producing E. coli strains from chicken carcasses and humans infections by PFGE and MLST
Table 2 Antimicrobial resistance profiles, presence of resistance genes and ISEcp1 in AmpC beta-lactamase positive E. coli strains
Strains Antimicrobial resistance profile to non beta-lactams Betalactamase genes Non beta-lactam resistance genes ISEcp1
Chicken carcass
23EC tet, gen, nal, sut blaCMY-2 tetA, tetB, sulI, sulII +
30C tet, gen, clo, nal, cip, nor, enr, sut blaCMY-2 tetB, sulI, sulII +
30TE tet, nal, sut blaCMY-2 tetA, tetB, sulI, sulII +
32.2 A tet, nal, sut blaCMY-2 tetA, tetB, sulI, sulII +
33.3 tet, nit, nal, cip, enr blaCMY-2 tetA, tetB, sulI, sulII +
33.5 tet, nal, cip, nor, enr, sut blaCMY-2 tetA, tetB, sulI, sulII –
43.5 tet, gen, clo, nit, sut blaCMY-2 tetA, sulI, sulII –
44.2 A tet, nal, sut blaCMY-2 tetA, sulI +
Human samples
U79167 tet, nal, cip, nor, enr, sut blaCMY-2; blaTEM-1 tetA +
U7895 tet, nal, cip, nor, enr, sut blaCMY-2 tetA –
T746 tet, nal, cip, nor, enr, sut blaCMY-2; blaTEM-1 tetB –
U7772 tet, gen, nal,cip, nor, enr, sut blaCMY-2 tetB +
S8293 tet, nit, nal, nor, enr blaCMY-2 tetB, sulII +
S4474 nal, cip, nor, enr blaCMY-2 – +
tetracycline (tet), gentamicin (gen), chloramphenicol (clo), nitrofurantoin (nit), nalidixic acid (nal), ciprofloxacin (cip), norfloxacin (nor), enrofloxacin (enr),
trimethoprim-sulfamethoxazole (sut)
(+) Presence
(−) Absence
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were only observed in human medical settings. FOX-5 like
and CMY-2-like were the first pAmpC beta-lactamases re-
ported in Brazilian isolates and were detected in E. coli
from patients in hospitals [10, 11]. Studies have shown an
increase in the frequency of pAmpC in human clinical set-
ting, but few studies have described the frequency of
pAmpC in Enterobacteriaceae in Brazil [6, 11, 28, 29].
However, since 2015, studies have found pAmpC-pro-
ducing bacteria in food-producing animals, mainly
chicken meat in Brazil, leading to the hypothesis that
this might become an infection source or reservoir that
contributes to the spread of these bacteria. The blaCMY-2
gene is also the pAmpC variant more frequently found
in food-producing animals in Brazil [12–16, 30]. Studies
have detected a high prevalence of blaCMY-2 genes
harbored on different plasmids in E. coli from poultry
[13, 14]. In Brazil, da Silva and collaborators (2017)
[16] found blaCMY-2 in avian pathogenic E. coli
(APEC) from turkey, with airsacculitis, showing that
this antimicrobial resistance mechanism can also be
found in pathogenic strains.
The true rate of occurrence of pAmpC in strains of E.
coli remains unknown because only a few surveillance
studies have examined this resistance mechanism in
Brazil [6]. Moreover, the lack of a standardized pheno-
typic method for the detection of AmpC-producing
isolates contributes to underreporting in human clinical
laboratories and veterinary medicine [5]. This higher
frequency of pAmpC found in food-producing animals
in recent years may be linked to changes in molecular
epidemiology of AmpC beta-lactamase and to the
indiscriminate use of antimicrobials in the production of
these animals, which may be selecting this resistance
mechanism.
Infections caused by pAmpC-producing bacteria limit
therapeutic options since these organisms are usually re-
sistant to all beta-lactam antibiotics, except cefepime,
cefpirome, and the carbapenems [5]. In our study, all
strains were considered multidrug-resistant and were
nonsusceptible to at least 1 agent in 3 or more anti-
microbial categories [27]. The highest frequencies of
resistance to non-beta-lactam antimicrobials were for
tetracycline (92.86%), nalidixic acid (92.86%) and sulfa-
methoxazole-trimethoprim (78.57%). In addition, by
PCR, our strains showed that chicken meat is a reservoir
of non-beta-lactam resistance genes such as tetA, tetB,
sulI and sulII (Table 2), which corroborates the high fre-
quency of phenotypic resistance for tetracycline and
sulfamethoxazole-trimethoprim. In addition, two strains
from humans have the blaTEM-1 gene, which encodes a
beta-lactamase with a lower spectrum of action. The
blapAmpC genes are usually present in mobile genetic
elements, which carry resistance genes encoding other
beta-lactamases and/or genes encoding resistance to
other classes of antimicrobials, as pAmpC-producing
bacteria are commonly multiresistant [5]. Co-resistance
phenotypes are involved in the maintenance of resist-
ance genes and plasmids in E. coli thus, the use of anti-
microbials in animal production may also play a role in
the selection of multidrug-resistant isolates in the ani-
mals’ environment [4].
A variety of genetic elements has been implicated in
the mobilization of blaampC genes onto plasmids. It has
been reported that beta-lactamase genes can be genetic-
ally linked to an upstream insertion elements, as ISEcp1.
Many studies have shown that blaAmpC- type genes are
associated with mobile genetic elements, including inser-
tion sequences such as ISEcp1, most of which are carried
on transferable plasmids [5, 31, 32]. In Brazil, only one
study reported the presence of the ISEcp 1-blaCMY-2
gene present on a plasmid from an E. coli strain isolated
from chickens [13]. In our study, six strains from
chicken carcasses and four strains from humans infec-
tion (71.4% of the total strains) showed the blaCMY-2
gene linked to an upstream ISEcp 1-like element. This
insertion element can be responsible for the trans-
position of blaCMY-2 to different plasmids and can also
have an important role in the dissemination of CMY-2
beta-lactamases.
MLST is a methodology that can reflect the microevo-
lution of the E. coli core genome, providing a true pic-
ture of the population structure of this bacterial species
[4]. Eleven STs were found in this study (Fig. 1), all of
which were reported both in birds and humans, with the
exception of ST3177, which has never been reported in
birds. All the STs have been reported in Brazil, with the
exception of ST448 and ST3177 [4, 13, 33–42]. STs 10,
57, 93 and 117 were reported in avian pathogenic E. coli
(APEC) and extraintestinal pathogenic E. coli (ExPEC) in
Brazil, showing that these strains may be related to
strains pathogenic, for both poultry and humans [38].
Four strains were grouped as ST354 (3 strains isolated
from human infection and 1 strain isolated from a
chicken carcass) suggested the possibility that they share
the same clonal origin. However, PFGE revealed consid-
erable heterogeneity among these strains. The most
closely related strains were the 2 strains isolated from
urine and tissue of human infection. PFGE also revealed
13 different PFGE types, with the dendrogram clearly
showing a good distinction between the strains isolated
from humans and chicken carcasses (Fig. 1). These data
suggest a high diversity of strains that carry pAmpC
genes and show possible parallel microevolution [4].
According to our study, we found a diverse E. coli
population from both chicken carcasses and in human
infection carrying the blaCMY-2 gene. Some studies also
concluded that dissemination of AmpC-producing E. coli
does not occur by clonal strains in these hosts [43, 44].
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However, in our study, the presence of ISEcp1 upstream
of blaCMY-2 in some strains suggests that mobile genetic
elements are being disseminated between bacteria from
humans and animals, mainly poultry.
Antimicrobials are normally used in animal husbandry
as veterinary drugs or feed additives [45]. Although a
withdrawal time for antimicrobial use is required before
the animal is sacrificed for sale, Wang and collaborators
(2017) found residues of antimicrobials in meat and even
detected some human antimicrobials, that are not used
as veterinary drugs. The spread of antimicrobial resist-
ance genes in poultry may be associated with the
prophylactic use of cephalosporins injected into eggs to
control E. coli omphalitis in broiler chickens [46]. In
Brazil, third-generation cephalosporins have been asso-
ciated with in ovo vaccination on the 18th day of incuba-
tion because the vaccine can also select antimicrobial
resistant bacteria in poultry [33].
Further research about the dissemination of resist-
ant bacteria need to be conducted in a given time
and geographical area to trace the flow of resistant
bacteria because there are few studies about this
dissemination [4]. Our study allows us to understand
some aspects of the dissemination of this resistance
mechanism in a restricted area, which is important
step for developing strategies aimed at preventing the
propagation of this resistance through food ingestion.
These data show the presence of the blaCMY-2 gene
linked with an ISEcp1-type insertion element in both
chicken carcasses and in human infection in a re-
stricted region. Our results suggest the presence of
highly diverse strains that harbor pAmpC, indicating
no clonal dissemination. In a “One-Health” context,
continuous collaboration among professionals in hu-
man and animal healthcaree, the food industry and
the environmental sector is needed to characterize
the occurrence and routes of dissemination of these
antimicrobial resistance determinants.
Conclusion
Since Brazil is one of the largest exporters of chicken
meat in the world, surveillance studies are essential to
identify resistance genes and bacterial clones that may
spread from chickens to humans. Our results show the
presence of highly diverse strains that harbor pAmpC,
indicating no clonal dissemination. However, the
presence of blaCMY-2, linked to the ISEcp1 element, was
present both in chicken meat and human infection,
suggesting that mobile genetic elements can be respon-
sible for the spread of this resistance mechanism in this
restricted area. Therefore, continuous monitoring and
comparative analyses of resistant bacteria from humans
and food-producing animals are needed.
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